KCI BioTech (Suzhou) Inc. and its wholly-owned subsidiary Jiangsu KMQ BioTech Inc. are committed to providing comprehensive preclinical new drug discovery and development services for global pharmaceutical companies and research institutions, and establishing a professional and efficient drug research and development evaluation system.
       With a professional integrated R&D team and rich experience in in vivo pharmacology and pharmacodynamics, our company has gained a large market share in the high technical barrier and huge demand preclinical research field. We have cooperated with over 500 well-known pharmaceutical R&D companies both domestically and internationally, and have completed over 100 domestic and international new drug application projects......